Adaptimmune Therapeutics
ADAP
#4046
Rank
$0.89 B
Marketcap
🇬🇧 UK
Country
$5.76
Share price
0.17%
Change (1 day)
N/A
Change (1 year)
Categories
Market capitalization of Adaptimmune Therapeutics (ADAP)
Market cap: $0.89 Billion
As of September 2021 Adaptimmune Therapeutics has a market cap of $0.89 Billion. This makes Adaptimmune Therapeutics the world's 4046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Adaptimmune Therapeutics from 2015 to 2021
| Year | Market cap | Change |
|---|---|---|
| 2021 | $0.80 B | -40.78% |
| 2020 | $1.35 B | 975.66% |
| 2019 | $0.12 B | -79.01% |
| 2018 | $0.60 B | -3.92% |
| 2017 | $0.62 B | 118.3% |
| 2016 | $0.28 B | -66.42% |
| 2015 | $0.85 B |